Published in Gene Therapy Weekly, August 25th, 2005
Before joining XOMA, Solinger was director of clinical research at Amgen, Inc. where he participated in the design of the clinical and commercial strategies for marketed products Enbrel (Etanercept) and Kineret (Anakinra), and for other late-stage products. Prior to that he was medical director for Parexel International, Inc.
Solinger received his bachelor's degree in chemical biology from Columbia University...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.